Login / Signup

A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key Stakeholders.

Iselin Dahlen SyversenKevin SchulmanAaron S KesselheimWilliam B Feldman
Published in: The Milbank quarterly (2024)
High-income countries around the world adopt different approaches to conducting price negotiations on brand-name drugs but coalesce around a set of practices that will largely be absent from the current Medicare negotiation framework. US policymakers might consider adding some of these characteristics in the future to improve negotiation outcomes.
Keyphrases
  • healthcare
  • primary care
  • physical activity
  • mental health
  • emergency department
  • current status
  • type diabetes
  • skeletal muscle
  • adverse drug
  • metabolic syndrome
  • weight loss
  • affordable care act